Cephalomannine and its use in treating leukemic tumors

Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260333, C07D30514, A61K 31335

Patent

active

042062217

ABSTRACT:
A novel alkaloid named "cephalomannine" has been produced from the tissue of plants belonging to the group commonly known as taxads and has proven to be effective in causing the remission of leukemic tumors in mice treated therewith. Cephalomannine is characterized by the following structural formula: ##STR1##

REFERENCES:
J. M. Kingsbury, Poisonous Plants of the United States and Canada (1964), pp. 121-123.
M. C. Wani et al., J. Amer. Chem. Soc., vol. 93 (1971), pp. 2325-2327.
D. K. Ferguson, Review of Palaeobotany and Palynology, vol. 26 (1978), pp. 213-226.
Cancer Research, Part 2, vol. 26, No. 3, Mar. 1966, pp. 218 and 348.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cephalomannine and its use in treating leukemic tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cephalomannine and its use in treating leukemic tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cephalomannine and its use in treating leukemic tumors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-716019

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.